TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+23.12%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$182M
AUM Growth
+$182M
(-5.5%)
Cap. Flow
+$6.48M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
1
Increased
2
Reduced
1
Closed
3
Top Buys
| 1 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$4.3M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.45M |
| 3 |
Achieve Life Sciences
ACHV
|
$836K |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$926K |
| 2 |
Phio Pharmaceuticals
PHIO
|
$100K |
| 3 |
DNDN
DENDREON CORPORATION
DNDN
|
$80K |
Sector Composition
| 1 | Healthcare | 64.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Heron Therapeutics
HRTX
$207M
| $49.5M | 27.14% | 4,919,625 | – | – |
|
|
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $39.6M | 21.69% | 2,144,387 +232,925 | +12% | +$4.3M |
|
|
SLXP
3
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $34.5M | 18.91% | 300,000 | – | – |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $16.5M | 9.04% | 182,300 | – | – |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.32M | 3.46% | 490,000 +190,000 | +63% | +$2.45M |
|
|
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.42M | 2.42% | 238,432 -50,000 | -17% | -$926K |
|
|
7
Achieve Life Sciences
ACHV
$152M
| $836K | 0.46% | +365,000 | New | +$836K |
|
|
8
Phio Pharmaceuticals
PHIO
$11.3M
| – | – | -50,219 | Closed | -$100K |
|
|
DNDN
9
DELISTED
DENDREON CORPORATION
DNDN
| – | – | -55,548 | Closed | -$80K |
|
|
AMBI
10
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| – | – | -46 | Closed | – |
|